Drug Trial Radar · NCT07734493
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Aug 3, 2026
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Leal Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Jul 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to learn whether the investigational drug LTX-001 is safe and well tolerated in adults with a diagnosis of schizophrenia who are having a recent worsening of their symptoms (an acute exacerbation). Additional questions it aims to answer are: * how does the amount of the study drug in the body change over time (pharmacokinetics) * how does the study drug affect the symptoms of schizophrenia * how do certain markers in the blood change after administration of LTX-001 (pharmacodynamics) Researchers will compare different dose levels of LTX-001 to an inactive product (placebo) to see what differences there are between the two treatments. After successfully screening for the study, participants will stay in a research unit for about five weeks and return one week later for a follow-up visit.
Conditions
- Schizophrenia
Interventions
LTX-001 once dailyDrug
LTX-001 40 mg and 60 mg administered as oral suspension
PlaceboDrug
Oral suspension without LTX-001
LTX-001 twice dailyDrug
LTX-001 30 mg and 60 mg administered as oral suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and Tolerability - Adverse EventsTime frame: Screening through Day 42
- Safety and Tolerability - Clinical Laboratory TestsTime frame: Screening through Day 42
- Safety and Tolerability - Electrocardiograms (ECG)Time frame: Screening through Day 42
- Safety and Tolerability - Physical and Neurological ExamsTime frame: Screening through Day 42
- Safety and Tolerability - SuicidalityTime frame: Screening through Day 42
- Safety and Tolerability - Extrapyramidal SymptomsTime frame: Screening through Day 42
- Vital signs - blood pressureTime frame: Screening through Day 42
- Vital Signs - heart rateTime frame: Screening through Day 42
- Vital Signs - respiratory rateTime frame: Screening through Day 42
- Vital Signs - body temperatureTime frame: Screening through Day 42
- Vital Signs - total body weightTime frame: Screening through Day 42
- Vital Signs - heightTime frame: Screening through Day 42
- Vital Signs - Body Mass Index (BMI)Time frame: Screening through Day 42
- Ocular evaluation - Best Corrected Visual Acuity (BCVA)Time frame: Screening through Day 42
- Ocular evaluation - dilated Color Fundus Photography (CFP)Time frame: Screening through Day 42
- Ocular evaluation - Fundus Autofluorescence (FAF)Time frame: Screening through Day 42
- Ocular evaluation - dilated Optical Coherence Tomography (OCT)Time frame: Screening through Day 42
- Ocular evaluation - slit lamp examinationTime frame: Screening through Day 42
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Pillar Clinical Research, LLC
Little Rock, Arkansas · Recruiting
Collaborative Neuroscience Research, LLC
Los Alamitos, California · Recruiting
University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida · Recruiting
Behavioral Clinical Research, Inc.
Hollywood, Florida · Recruiting
CenExel Hollywood FL
Hollywood, Florida · Recruiting
Innovative Clinical Research, Inc.
Miami Lakes, Florida · Recruiting
CenExel iResearch, LLC
Decatur, Georgia · Recruiting
CBH Health LLC., dba CenExel Gaithersburg MD
Gaithersburg, Maryland · Recruiting
Hassman Research Institute, LLC
Marlton, New Jersey · Recruiting
Pillar Clinical Research, LLC
Richardson, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.